These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37750202)

  • 1. Atezolizumab-induced myositis in a patient with small-cell lung cancer.
    Sahin E; Cabuk D; Tuncer Kuru F; Yazici A
    J Oncol Pharm Pract; 2024 Jan; 30(1):220-224. PubMed ID: 37750202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atezolizumab-induced myositis and myocarditis in a patient with metastatic urothelial carcinoma.
    Sessums M; Yarrarapu S; Guru PK; Sanghavi DK
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33298477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.
    Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H
    Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature.
    Saad R; Ghaddar A; Zeenny RM
    J Med Case Rep; 2024 Feb; 18(1):107. PubMed ID: 38383436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myositis as a neuromuscular complication of immune checkpoint inhibitors.
    Vermeulen L; Depuydt CE; Weckx P; Bechter O; Van Damme P; Thal DR; Claeys KG
    Acta Neurol Belg; 2020 Apr; 120(2):355-364. PubMed ID: 31993961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication.
    Zhao Y; Peng W; Abbas M; Shi M; Tang Y; Wang L; Yan H
    Invest New Drugs; 2022 Feb; 40(1):209-214. PubMed ID: 34398354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.
    Kamo H; Hatano T; Kanai K; Aoki N; Kamiyama D; Yokoyama K; Takanashi M; Yamashita Y; Shimo Y; Hattori N
    BMC Neurol; 2019 Aug; 19(1):184. PubMed ID: 31382909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myositis as an adverse event of immune checkpoint blockade for cancer therapy.
    Shah M; Tayar JH; Abdel-Wahab N; Suarez-Almazor ME
    Semin Arthritis Rheum; 2019 Feb; 48(4):736-740. PubMed ID: 29909921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer.
    Kunii E; Owaki S; Yamada K; Yoshihara M; Yamaba Y; Takakuwa O; Toyoda T; Akita K
    Intern Med; 2022 Jun; 61(11):1739-1742. PubMed ID: 34707051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral retrobulbar optic neuritis combined with optic perineuritis associated with atezolizumab treatment for small cell lung carcinoma.
    Zhang J; Wang L; Zhang L; Liu H; Yang B; Jiang L
    Eur J Ophthalmol; 2024 May; 34(3):NP29-NP33. PubMed ID: 38178774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 75-Year-Old Female Smoker with Advanced Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status 2 who Responded to Combination Immunochemotherapy with Atezolizumab, Etoposide, and Carboplatin.
    Dębczyński M; Mojsak D; Kuklińska B; Mróz RM
    Am J Case Rep; 2022 Aug; 23():e936536. PubMed ID: 35949112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings.
    Imai R; Ono M; Nishimura N; Suzuki K; Komiyama N; Tamura T
    J Thorac Oncol; 2019 Feb; 14(2):e36-e38. PubMed ID: 30391574
    [No Abstract]   [Full Text] [Related]  

  • 13. Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer: A case report and literature review.
    Kapagan T; Aksu F; Yuzkan S; Bulut N; Erdem GU
    J Oncol Pharm Pract; 2024 Jan; 30(1):201-205. PubMed ID: 37321205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer.
    Kataoka N; Kunimatsu Y; Tachibana Y; Sugimoto T; Sato I; Tani N; Ogura Y; Hirose K; Takeda T
    Thorac Cancer; 2020 Sep; 11(9):2740-2742. PubMed ID: 32706170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
    Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
    Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
    J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report.
    Cham J; Ng D; Nicholson L
    J Med Case Rep; 2021 May; 15(1):278. PubMed ID: 34053457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of atezolizumab- and bevacizumab-induced myositis showing high intensity in the pterygoid muscles, soft palate, and tongue on STIR-MRI].
    Ono S; Nakamura M; Morise S; Kunieda T; Yakushiji Y
    Rinsho Shinkeigaku; 2023 Sep; 63(9):582-587. PubMed ID: 37648475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe inflammatory myopathy in a pulmonary carcinoma patient treated with Pembrolizumab: An alert for myologists.
    Peverelli L; De Rosa A; Domina E; Ciscato P; Sita G; Velardo D; Comi GP
    J Neuromuscul Dis; 2020; 7(4):511-514. PubMed ID: 32623405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atezolizumab: A Review in Extensive-Stage SCLC.
    Frampton JE
    Drugs; 2020 Oct; 80(15):1587-1594. PubMed ID: 32990939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.